The term "stem cells" refers to a variety of cells that have self-renewal and differentiation capabilities, many of which could be used therapeutically. As more stem cell-based medicines reach clinical trials, the necessity for strong methodologies and consistent procedures capable of reliably delivering the required volumes of cells while verifying the product's safety and usefulness becomes obvious. Over the last 50–60 years, the stem cell field has advanced dramatically. The development of cell-engineering techniques has ushered in a new era of stem cell-based therapeutics, considerably extending their therapeutic potential. These next-generation stem cells are being employed as 'Trojan horses' to increase medicine and oncolytic virus delivery to stubborn tumours, and they're also being modified with angiogenic, neurotrophic, and anti-inflammatory chemicals to speed tissue healing.
Title : Electroactive polymer-based smart scaffolds for tissue engineering and regenerative medicine
Federico Carpi, University of Florence, Italy
Title : Liver cell therapies: From hepatocyte transplant to placental stem cell infusion
Roberto Gramignoli, Karolinska Institutet, Sweden
Title : The common cure for all cancers- clue from cancer stem cells
Pushpam Kumar Sinha, Independent Researcher, India
Title : Stem cell therapy in radiotherapy from bench to clinical trial evaluating the efficacy of mesenchymal stromal cell injections for the treatment of chronic pelvic complications induced by radiation therapy
Alain chapel, Institute of Radiological Protection and Nuclear Safety, France
Title : Stem cell-induced proliferation on the hippocampus after intranasal administration of Galanin receptor 2 and neuropeptide Y1 receptor agonists: Role in spatial memory and depression-like effects in rats
Manuel Narvaez Pelaez, Malaga University, Spain
Title : Msc-exosomes in osteoarthritis treatment
Neus Figa Martin, Clínica Exolife, Spain